HopeStage
Back to all studies
CompletedNCT01042496

Brain chemistry before and after lamotrigine for depression in bipolarity

About this title

Bipolar Depression Before and After Lamotrigine Treatment

Read the official source — NCT01042496
Medication studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
RochesterSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateDecember 2009
Recruitment status
Completed
Enrollment listed in the registry
72
Sponsor
Mayo Clinic
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug, Procedure
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT01042496
Official title
Show the full official title

1H-MR Spectroscopy of Bipolar Depression Before and After Lamotrigine Treatment

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Rochester

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Mayo Clinic, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including lamotrigine.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies